Blinatumomab produced remission in high-risk patients with Ph+ B-Cell precursor acute lymphoblastic leukemia May 01, 2017Vol.40 No.04
Conversation with The Cancer Letter No future collaborations with NantHealth are planned, U of Utah says April 28, 2017Vol.43 No.17
Tom Curran: Contract between NantHealth and U of Utah “seems a bit expensive” April 28, 2017Vol.43 No.17By Tom Curran
Soon-Shiong and The Art of the Deal:Billionaire gives $12M to the U of Utah, takes $10M in orders for his company April 28, 2017Vol.43 No.17By Paul Goldberg
U of Utah department chairs urge colleagues to sign petition supporting Vivian Lee April 28, 2017Vol.43 No.17
Beckerle reinstated as director of Huntsman Cancer Institute April 28, 2017Vol.43 No.17By Matthew Bin Han Ong
FDA: “Rational” expansion of eligibility criteria for clinical trials would accelerate drug development April 21, 2017Vol.43 No.16
